Description
“SARS-CoV-2&Influenza A/B Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2, Influenza A and Influenza B virus antigen in anterior nasal swabs from individuals suspected of COVID-19, Influenza A and Influenza B within the first seven days of symptom onset.”